{"id":483513,"date":"2021-04-28T16:03:12","date_gmt":"2021-04-28T20:03:12","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/safirstein-metcalf-llp-announces-that-a-class-action-has-been-filed-against-emergent-biosolutions-inc-ebs\/"},"modified":"2021-04-28T16:03:12","modified_gmt":"2021-04-28T20:03:12","slug":"safirstein-metcalf-llp-announces-that-a-class-action-has-been-filed-against-emergent-biosolutions-inc-ebs","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/safirstein-metcalf-llp-announces-that-a-class-action-has-been-filed-against-emergent-biosolutions-inc-ebs\/","title":{"rendered":"Safirstein Metcalf LLP Announces That A Class Action Has Been Filed Against Emergent BioSolutions Inc. – EBS"},"content":{"rendered":"
\n

NEW YORK, April 28, 2021 (GLOBE NEWSWIRE) — Safirstein Metcalf LLP notifies investors that a class action lawsuit has been filed against Emergent BioSolutions Inc. (“Emergent” or “the Company”) (NYSE: EBS) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Emergent securities between\u00a0July 6, 2020 and March 31, 2021,\u00a0both dates inclusive (the “Class Period”).<\/p>\n

If you purchased or acquired Emergent securities and would like more information, please contact Safirstein Metcalf LLP at 1-800-221-0015, or email info@SafirsteinMetcalf.com<\/a>.<\/p>\n

If you wish to serve as a lead plaintiff, you must move the Court no later than June 18, 2021. <\/strong> A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice or may choose to do nothing and remain an absent class member.<\/p>\n

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.<\/p>\n

The complaint alleges that throughout the Class Period, Defendants made materially false and\/or misleading statements and failed to disclose that: (1) Emergent BioSolution\u2019s Baltimore plant had a history of manufacturing issues increasing the likelihood for massive contaminations; (2) these longstanding contamination risks and quality control issues at Emergent BioSolution\u2019s facility led to a string of FDA citations; (3) the Company previously had to discard the equivalent of millions of doses of COVID-19 vaccines after workers at the Baltimore plant deviated from manufacturing standards; and (4) as a result of the foregoing, defendants\u2019 public statements about Emergent BioSolution\u2019s ability and capacity to mass manufacture multiple COVID-19 vaccines at its Baltimore manufacturing site were materially false and\/or misleading and\/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.<\/p>\n

About Safirstein Metcalf LLP<\/p>\n

Safirstein Metcalf LLP focuses its practice on shareholder rights. The law firm also practices in the areas of antitrust and consumer protection. All of the Firm\u2019s legal endeavors are rooted in its core mission: provide investor and consumer protection.<\/p>\n

Attorney advertising. Prior results do not guarantee a similar outcome.<\/p>\n

Safirstein Metcalf LLP
Peter Safirstein, Esq
1345 Avenue of the Americas
2nd Floor
New York, NY 10105
1-800-221-0015<\/p>\n

\u00a0<\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

NEW YORK, April 28, 2021 (GLOBE NEWSWIRE) — Safirstein Metcalf LLP notifies investors that a class action lawsuit has been filed against Emergent BioSolutions Inc. (“Emergent” or “the Company”) (NYSE: EBS) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Emergent securities between\u00a0July 6, 2020 and March 31, 2021,\u00a0both dates inclusive (the “Class Period”). If you purchased or acquired Emergent securities and would like more information, please contact Safirstein Metcalf LLP at 1-800-221-0015, or email info@SafirsteinMetcalf.com. If you wish to serve as a lead plaintiff, you must move the Court no later than June 18, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Any … <\/p>\n

Continue reading “Safirstein Metcalf LLP Announces That A Class Action Has Been Filed Against Emergent BioSolutions Inc. – EBS”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-483513","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nSafirstein Metcalf LLP Announces That A Class Action Has Been Filed Against Emergent BioSolutions Inc. - EBS - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/safirstein-metcalf-llp-announces-that-a-class-action-has-been-filed-against-emergent-biosolutions-inc-ebs\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Safirstein Metcalf LLP Announces That A Class Action Has Been Filed Against Emergent BioSolutions Inc. - EBS - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, April 28, 2021 (GLOBE NEWSWIRE) — Safirstein Metcalf LLP notifies investors that a class action lawsuit has been filed against Emergent BioSolutions Inc. (“Emergent” or “the Company”) (NYSE: EBS) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Emergent securities between\u00a0July 6, 2020 and March 31, 2021,\u00a0both dates inclusive (the “Class Period”). If you purchased or acquired Emergent securities and would like more information, please contact Safirstein Metcalf LLP at 1-800-221-0015, or email info@SafirsteinMetcalf.com. If you wish to serve as a lead plaintiff, you must move the Court no later than June 18, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Any … Continue reading "Safirstein Metcalf LLP Announces That A Class Action Has Been Filed Against Emergent BioSolutions Inc. – EBS"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/safirstein-metcalf-llp-announces-that-a-class-action-has-been-filed-against-emergent-biosolutions-inc-ebs\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-28T20:03:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTc0NSM0MTQ0ODAxIzIwNDk3MjI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/safirstein-metcalf-llp-announces-that-a-class-action-has-been-filed-against-emergent-biosolutions-inc-ebs\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/safirstein-metcalf-llp-announces-that-a-class-action-has-been-filed-against-emergent-biosolutions-inc-ebs\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Safirstein Metcalf LLP Announces That A Class Action Has Been Filed Against Emergent BioSolutions Inc. – EBS\",\"datePublished\":\"2021-04-28T20:03:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/safirstein-metcalf-llp-announces-that-a-class-action-has-been-filed-against-emergent-biosolutions-inc-ebs\\\/\"},\"wordCount\":396,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/safirstein-metcalf-llp-announces-that-a-class-action-has-been-filed-against-emergent-biosolutions-inc-ebs\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyNTc0NSM0MTQ0ODAxIzIwNDk3MjI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/safirstein-metcalf-llp-announces-that-a-class-action-has-been-filed-against-emergent-biosolutions-inc-ebs\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/safirstein-metcalf-llp-announces-that-a-class-action-has-been-filed-against-emergent-biosolutions-inc-ebs\\\/\",\"name\":\"Safirstein Metcalf LLP Announces That A Class Action Has Been Filed Against Emergent BioSolutions Inc. - EBS - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/safirstein-metcalf-llp-announces-that-a-class-action-has-been-filed-against-emergent-biosolutions-inc-ebs\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/safirstein-metcalf-llp-announces-that-a-class-action-has-been-filed-against-emergent-biosolutions-inc-ebs\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyNTc0NSM0MTQ0ODAxIzIwNDk3MjI=\",\"datePublished\":\"2021-04-28T20:03:12+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/safirstein-metcalf-llp-announces-that-a-class-action-has-been-filed-against-emergent-biosolutions-inc-ebs\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/safirstein-metcalf-llp-announces-that-a-class-action-has-been-filed-against-emergent-biosolutions-inc-ebs\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/safirstein-metcalf-llp-announces-that-a-class-action-has-been-filed-against-emergent-biosolutions-inc-ebs\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyNTc0NSM0MTQ0ODAxIzIwNDk3MjI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyNTc0NSM0MTQ0ODAxIzIwNDk3MjI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/safirstein-metcalf-llp-announces-that-a-class-action-has-been-filed-against-emergent-biosolutions-inc-ebs\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Safirstein Metcalf LLP Announces That A Class Action Has Been Filed Against Emergent BioSolutions Inc. – EBS\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Safirstein Metcalf LLP Announces That A Class Action Has Been Filed Against Emergent BioSolutions Inc. - EBS - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/safirstein-metcalf-llp-announces-that-a-class-action-has-been-filed-against-emergent-biosolutions-inc-ebs\/","og_locale":"en_US","og_type":"article","og_title":"Safirstein Metcalf LLP Announces That A Class Action Has Been Filed Against Emergent BioSolutions Inc. - EBS - Market Newsdesk","og_description":"NEW YORK, April 28, 2021 (GLOBE NEWSWIRE) — Safirstein Metcalf LLP notifies investors that a class action lawsuit has been filed against Emergent BioSolutions Inc. (“Emergent” or “the Company”) (NYSE: EBS) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Emergent securities between\u00a0July 6, 2020 and March 31, 2021,\u00a0both dates inclusive (the “Class Period”). If you purchased or acquired Emergent securities and would like more information, please contact Safirstein Metcalf LLP at 1-800-221-0015, or email info@SafirsteinMetcalf.com. If you wish to serve as a lead plaintiff, you must move the Court no later than June 18, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Any … Continue reading \"Safirstein Metcalf LLP Announces That A Class Action Has Been Filed Against Emergent BioSolutions Inc. – EBS\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/safirstein-metcalf-llp-announces-that-a-class-action-has-been-filed-against-emergent-biosolutions-inc-ebs\/","og_site_name":"Market Newsdesk","article_published_time":"2021-04-28T20:03:12+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTc0NSM0MTQ0ODAxIzIwNDk3MjI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/safirstein-metcalf-llp-announces-that-a-class-action-has-been-filed-against-emergent-biosolutions-inc-ebs\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/safirstein-metcalf-llp-announces-that-a-class-action-has-been-filed-against-emergent-biosolutions-inc-ebs\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Safirstein Metcalf LLP Announces That A Class Action Has Been Filed Against Emergent BioSolutions Inc. – EBS","datePublished":"2021-04-28T20:03:12+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/safirstein-metcalf-llp-announces-that-a-class-action-has-been-filed-against-emergent-biosolutions-inc-ebs\/"},"wordCount":396,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/safirstein-metcalf-llp-announces-that-a-class-action-has-been-filed-against-emergent-biosolutions-inc-ebs\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTc0NSM0MTQ0ODAxIzIwNDk3MjI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/safirstein-metcalf-llp-announces-that-a-class-action-has-been-filed-against-emergent-biosolutions-inc-ebs\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/safirstein-metcalf-llp-announces-that-a-class-action-has-been-filed-against-emergent-biosolutions-inc-ebs\/","name":"Safirstein Metcalf LLP Announces That A Class Action Has Been Filed Against Emergent BioSolutions Inc. - EBS - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/safirstein-metcalf-llp-announces-that-a-class-action-has-been-filed-against-emergent-biosolutions-inc-ebs\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/safirstein-metcalf-llp-announces-that-a-class-action-has-been-filed-against-emergent-biosolutions-inc-ebs\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTc0NSM0MTQ0ODAxIzIwNDk3MjI=","datePublished":"2021-04-28T20:03:12+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/safirstein-metcalf-llp-announces-that-a-class-action-has-been-filed-against-emergent-biosolutions-inc-ebs\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/safirstein-metcalf-llp-announces-that-a-class-action-has-been-filed-against-emergent-biosolutions-inc-ebs\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/safirstein-metcalf-llp-announces-that-a-class-action-has-been-filed-against-emergent-biosolutions-inc-ebs\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTc0NSM0MTQ0ODAxIzIwNDk3MjI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTc0NSM0MTQ0ODAxIzIwNDk3MjI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/safirstein-metcalf-llp-announces-that-a-class-action-has-been-filed-against-emergent-biosolutions-inc-ebs\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Safirstein Metcalf LLP Announces That A Class Action Has Been Filed Against Emergent BioSolutions Inc. – EBS"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/483513","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=483513"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/483513\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=483513"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=483513"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=483513"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}